Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

49 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Five-year safety and performance data of a novel third-generation novolimus-eluting bioresorbable scaffold in single de novo lesions.
Verheye S, Costa RA, Schofer J, Ormiston JA, Maeng M, Dudek D, Skurk C, Botelho RV, Costa JR, Chamié D, Abizaid AS, Boersma E, Abizaid AA. Verheye S, et al. Among authors: abizaid aa, abizaid as. EuroIntervention. 2019 Oct 20;15(8):685-687. doi: 10.4244/EIJ-D-18-00292. EuroIntervention. 2019. PMID: 30530403 Free article. No abstract available.
Twelve-month clinical and imaging outcomes of the uncaging coronary DynamX bioadaptor system.
Verheye S, Vrolix M, Montorfano M, Zivelonghi C, Giannini F, Bedogni F, Dubois C, De Bruyne B, Costa RA, Chamié D, de Ribamar Costa J Jr, Kereiakes DJ, Abizaid AA, Colombo A. Verheye S, et al. Among authors: abizaid aa. EuroIntervention. 2020 Dec 18;16(12):e974-e981. doi: 10.4244/EIJ-D-20-00763. EuroIntervention. 2020. PMID: 32894231 Free article.
Long-Term Follow-Up of Patients after Percutaneous Coronary Intervention with Everolimus-Eluting Bioresorbable Vascular Scaffold.
Meneguz-Moreno RA, Costa JR Junior, Moscoso FA, Staico R, Tanajura LF, Centemero MP, Chaves AJ, Abizaid AC, Sousa AG, Abizaid AA. Meneguz-Moreno RA, et al. Among authors: abizaid aa, abizaid ac. Arq Bras Cardiol. 2017 Feb;108(2):109-115. doi: 10.5935/abc.20160202. Epub 2017 Jan 9. Arq Bras Cardiol. 2017. PMID: 28076449 Free PMC article.
Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy.
Jensen CJ, Naber CK, Urban P, Ong PJ, Valdes-Chavarri M, Abizaid AA, Pocock SJ, Fabbiocchi F, Dubois C, Copt S, Stoll HP, Morice MC. Jensen CJ, et al. Among authors: abizaid aa. EuroIntervention. 2018 Mar 20;13(16):1946-1949. doi: 10.4244/EIJ-D-17-00720. EuroIntervention. 2018. PMID: 29336310 Free article. Clinical Trial. No abstract available.
Randomised evaluation of a novel biodegradable polymer-based sirolimus-eluting stent in ST-segment elevation myocardial infarction: the MASTER study.
Valdes-Chavarri M, Kedev S, Neskovic AN, Morís de la Tassa C, Zivkovic M, Trillo Nouche R, Vázquez González N, Bartorelli AL, Antoniucci D, Tamburino C, Colombo A, Abizaid AA, McFadden E, Garcia-Garcia HM, Milasinovic D, Stankovic G. Valdes-Chavarri M, et al. Among authors: abizaid aa. EuroIntervention. 2019 Apr 5;14(18):e1836-e1842. doi: 10.4244/EIJ-D-17-01087. EuroIntervention. 2019. PMID: 29957593 Free article.
Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a Leaders Free ACS sub-study.
Naber CK, Urban P, Ong PJ, Valdes-Chavarri M, Abizaid AA, Pocock SJ, Fabbiocchi F, Dubois C, Copt S, Greene S, Morice MC; LEADERS FREE Investigators. Naber CK, et al. Among authors: abizaid aa. Eur Heart J. 2017 Apr 1;38(13):961-969. doi: 10.1093/eurheartj/ehw203. Eur Heart J. 2017. PMID: 27190095 Free PMC article. Clinical Trial.
49 results